Skip to main content
. 2000 Jun;44(6):1506–1511. doi: 10.1128/aac.44.6.1506-1511.2000

TABLE 1.

Activities of methylenecyclopropane analogues against HCMV and MCMV in HFF or MEF

Drug EC50 (μM) for HCMV
EC50 (μM) for MCMV
Determined by CPE inhibition assay Determined by PR assay SIa Determined by PR assay SI
GCV 0.39 2.3 >170 2.0 >19.6
QYL-284A 1.0 1.3 >353 2.1 >219
QYL-438 0.04 1.2 >358 0.3 >1,430
QYL-468 3.4 9.8 >52.9 52.3 >9.9
QYL-546 11.2 15.9 >27.1 0.6 >488
QYL-587A 1.9 4.2 >110 55 >9.4
QYL-678c 7.6 25.0 >8.2 3.3 >62.4
QYL-685d 11.2 7.8 15.5 3.2 65.9
QYL-769 2.0 2.4 136.3 0.37 595
QYL-418 5.4 6.9 26.8 0.27 963
QYL-788 NTb 1.9 94.7 0.55 538
QYL-972e 0.22 4.5 7.6 0.24 525
QYL-941 1.5 5.3 76.2 0.4 650
QYL-975f 0.9 6.2 20.3 0.93 109
a

SI, selectivity index (CC50/EC50). EC50 values are from PR assays. CC50 values are obtained from Table 7

b

NT, not tested. 

c

Prodrug of QYL-438. 

d

Prodrug of QYL-546. 

e

Prodrug of QYL-941. 

f

Prodrug of QYL-769.